Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José Enrique Martínez-Rodríguez"'
Autor:
Enric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, Susana Sainz de la Maza, Sara Llufriu, Roberto Álvarez-Lafuente, Bonaventura Casanova, Manuel Comabella, Lluís Ramió-Torrentà, José Enrique Martínez-Rodríguez, Luis Brieva, Albert Saiz, Sara Eichau, José María Cabrera-Maqueda, Noelia Villarrubia, Mercedes Espiño, Francisco Pérez-Miralles, Xavier Montalbán, Mar Tintoré, Ana Quiroga-Varela, María Inmaculada Domínguez-Mozo, Fernando Rodríguez-Jorge, Juan Luís Chico-García, Daniel Lourido, José Carlos Álvarez-Cermeño, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
JAMA Neurology. 80:397
ImportanceThe value of serum neurofilament light chain (sNfL) levels for predicting long-term disability in patients with multiple sclerosis (MS) remains controversial.ObjectiveTo assess whether high sNfL values are associated with disability worseni
Autor:
Francisco Gascón-Giménez, Carmen Alcalá, Lluís Ramió-Torrentà, Paloma Montero, Jorge Matías-Guiu, Irene Gómez-Estevez, Celia Oreja-Guevara, Sara Gil-Perotín, Yolanda Blanco, María Carcelén, Carlos Quintanilla-Bordás, Lucienne Costa, Luisa Maria Villar, Jose Enrique Martínez-Rodriguez, José Andrés Domínguez, Carmen Calles, Inés González, Javier Sotoca, Agustin Oterino, Celia Lucas-Jimenez, Francisco Pérez-Miralles, Bonaventura Casanova
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionRituximab (RTX) is considered a potential therapeutic option for relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main objective of this work was to investigate the effectiveness and safety of rituxim
Externí odkaz:
https://doaj.org/article/a88c93d629e84c54ae63a9bf5ae7db28
Publikováno v:
Medicina Clínica. 119:749-754
Autor:
Elisa, Cuadrado-Godia, Elvira, Munteis, José Enrique, Martínez-Rodríguez, Claustre, Pont-Sunyer, Gràcia, Cucurella, Jaume, Roquer
Publikováno v:
Medicina clinica. 132(7)
Treatment with beta interferon (IFNbeta) might alter the lipid profile. Plasmatic levels of total cholesterol and low density lipoprotein-cholesterol have been associated with the number of plaques in magnetic resonance of patients with demyelinating